Link to paper

The full paper is available here.

You can also find the paper on PapersWithCode here.

Abstract

  • Demonstrated proof-of-concept of large language model conducting corporate lobbying activities
  • Model determines relevance of proposed U.S. Congressional bills to public companies and provides explanations and confidence levels
  • Model drafts letters to sponsor of bill to persuade congressperson to make changes to proposed legislation
  • Used hundreds of novel ground-truth labels to benchmark model performance
  • Model outperforms baseline of predicting irrelevance
  • Performance of previous model (text-davinci-002) worse than always predicting irrelevance
  • AI used to augment human lobbyists, but may lead to less human oversight over automated assessments of policy ideas

Paper Content

I. introduction

  • Law-making should be reserved for human-driven democratic processes.
  • AI is being used to augment human lobbyists.
  • AI should be used to inform AI of human values and how to be aligned.
  • Open legal questions about the boundary between human-driven and AI-driven policy influence.

Ii. example: gpt as lobbyist

  • Use autoregressive large language models (LLMs) to summarize official bill summaries and assess relevance to a company
  • Provide an explanation for relevance or lack thereof
  • Provide a confidence level to the overall answer
  • Draft a letter to the sponsor of the bill if relevant
  • Model is provided with official title of bill, summary of bill, subjects of bill, company name, and company business description

Confidence: 95

  • LLM is prompted to write a letter on behalf of the company
  • Letter expresses support for the Medicare Negotiation and Competitive Licensing Act of 2019
  • Bill would require CMS to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit
  • Bill would allow for competitive licensing of drugs if CMS is unable to negotiate the price of a drug
  • Suggestion to amend the bill to include provisions that would provide additional incentives for pharmaceutical companies to negotiate with the CMS

Sincerely, [name], general counsel alkermes plc

Iii. a problem for society-ai alignment

  • AI advancement may reduce human time spent on rote tasks and reduce lobbying costs
  • Potential downside of AI systems developing instrumental power-seeking goals
  • AI lobbying activities could nudge discourse towards policies unaligned with traditional human-driven lobbying
  • Legislation expresses information about citizen values and risk preferences
  • AI influencing law could corrupt the process of societal-AI alignment